Association of CYP17 and MTRR Gene Polymorphisms with Clinicopathological  Features of Breast Cancer Patients

Juliana De Oliveira Cruz; Verena Silva Santos; Jakeline Santos Oliveira; Samuel Dos Santos Oliveira; Claudia Leal Macedo; Sandra Mara Bispo Sousa

Authors

Juliana De Oliveira Cruz
Verena Silva Santos
Jakeline Santos Oliveira
Samuel Dos Santos Oliveira
Claudia Leal Macedo
Sandra Mara Bispo Sousa

Keywords:

Breast cancer, CYP17, MTRR, polymorphism

Abstract

Allele frequencies of T-34C CYP17 and A66G MTRR polymorphisms in breast cancer samples and the correlation with clinicopathological data can contribute to the prognosis and knowledge of the genetic profile of a population. In this study, was analized the association of T-34C CYP17 and A66G MTRR polymorphisms with clinicopathological data in 82 samples of invasive ductal breast carcinoma in the Southwest region of Bahia. PCR-RFLP was used to determine the genotypes for A66G MTRR and T-34C CYP17 polymorphisms. The allele frequency was 0.369 and 0.631 for A66G MTRR; 0.672 and 0.328 for T-34C CYP17. The A66G MTRR genotypes showed deviation from Hardy-Weinberg equilibrium (p=0.000), the genotypes are not segregating independently (p=0.036). No association of polymorphisms with clinicopathological features was observed.

Downloads

How to Cite

Association of CYP17 and MTRR Gene Polymorphisms with Clinicopathological Features of Breast Cancer Patients. (2020). Global Journal of Medical Research, 20(F7), 1-6. https://medicalresearchjournal.org/index.php/GJMR/article/view/2150

Download Citation

References

Kiyoko Abe-Sandes, Wilson Silva, Marco Zago (2004) Heterogeneity of the Y Chromosome in Afro-Brazilian Populations. 76(1), 77-86.

Paraskevi Apostolou, Florentia Fostira (2013) Hereditary Breast Cancer: The Era of New Susceptibility Genes. 2013, 1-11.

Aristea Binia, Alejandra Contreras, Samuel Canizales-Quinteros, Victor Alonzo, M Tejero, Irma Silva-Zolezzi (2014) Geographical and ethnic distribution of single nucleotide polymorphisms within genes of the folate/homocysteine pathway metabolism. 9(5), 421.

Teodoro Bottiglieri (2005) Homocysteine and folate metabolism in depression. 29(7), 1103-1112.

Adam Carey, Dawn Waterworth, Kirty Patel, Davinia White, Julie Little, Patricia Novelli, Stephen Franks, Robert Williamson (1994) Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. 3(10), 1873-1876.

Yun Chen, Jianping Pei (2010) Factors influencing the association between CYP17 T34C polymorphism and the risk of breast cancer: meta-regression and subgroup analysis. 122(2), 471-481.

Mark Clemons, Paul Goss (2001) Estrogen and the Risk of Breast Cancer. 344(4), 276-285.

Alastair Cribb, Marion Joy Knight, Judy Guernsey, Dagny Dryer, Kimberly Hender, Allam Shawwa, Marvin Tesch, Tarek Saleh (2011) CYP17, Catechol-O-Methyltransferase, and Glutathione Transferase M1 Genetic Polymorphisms, Lifestyle Factors, and Breast Cancer Risk in Women on Prince Edward Island. 17(1), 24-31.

Y Guo, D Xiong, T Yang, Y Guo, R Recker, H Deng (2006) Polymorphisms of estrogen-biosynthesis genes CYP17 and CYP19 may influence age at menarche: a genetic association study in Caucasian females. 15(16), 2401-2408.

T Hasan, R Arora, A Bansal, R Bhattacharya, G Sharma, L Singh (2019) Disturbed homocysteine metabolism is associated with cancer. 51(2), 1-13.

Mami Hiraoka, Yasuo Kagawa (2017) Genetic polymorphisms and folate status. 57(5), 142-149.

J Hu, G Zhou, N Wang, Y Wang (2010) MTRR A66G polymorphism and breast cancer risk: a meta-analysis. 124(3), 779-784.

Ikuko Kato, Michelle Cichon, Cecilia Yee, Susan Land, Jeannette Korczak (2009) African American-preponderant single nucleotide polymorphisms (SNPs) and risk of breast cancer. 33(1), 24-30.

Ekatherina Kuligina, Alexandr Togo, Evgeny Suspitsin, Maxim Grigoriev, Kazimir Pozharisskiy, Oleg Chagunava, Lev Berstein, Charles Theillet, Kaido Hanson, Evgeny Imyanitov (2000) CYP17 polymorphism in the groups of distinct breast cancer susceptibility: comparison of patients with the bilateral disease vs. monolateral breast cancer patients vs. middle-aged female controls vs. elderly tumor-free women. 156(1), 45-50.

Jenna Lilyquist, Kathryn Ruddy, Celine Vachon, Fergus Couch (2018) Common Genetic Variation and Breast Cancer Risk-Past, Present, and Future. 27(4), 380-394.

Siew‐kee Low, Hitoshi Zembutsu, Yusuke Nakamura (2018) Breast cancer: The translation of big genomic data to cancer precision medicine. 109(3), 497-506.

Wenju Mo, Yuqin Ding, Yurong Zheng, Dehong Zou, Xiaowen Ding (2020) Associations between folate metabolism enzyme polymorphisms and breast cancer: A meta‐analysis. 26(3), 484-487.

H Olteanu, T Munson, R Banerjee (2002) Differences in the Efficiency of Reductive Activation of Methionine Synthase and Exogenous Electron Acceptors between the Common Polymorphic Variants of Human Methionine Synthase Reductase. 13378-13385.

Kristin Rojas, Ashley Stuckey (2016) Breast Cancer Epidemiology and Risk Factors. 59(4), 651-672.

Stuart Schnitt (2010) Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy. 23, S60-S64.

S Shiovitz, L Korde (2015) Genetics of breast cancer: a topic in evolution. 26(7), 1291-1299.

Michael Stratton, Nazneen Rahman (2008) The emerging landscape of breast cancer susceptibility. 40(1), 17-22.

Jing Sun, Hong Zhang, Meiyan Gao, Zhishu Tang, Dongyan Guo, Xiaofei Zhang, Zhu Wang, Ruiping Li, Yan Liu, Wansen Sun, Xi Sun (2018) Association between CYP17 T-34C rs743572 and breast cancer risk. 9(3), 4200-4213.

Takeshi Suzuki, Keitaro Matsuo, Kaoru Hirose, Akio Hiraki, Takakazu Kawase, Miki Watanabe, Toshinari Yamashita, Hiroji Iwata, Kazuo Tajima (2008) One-carbon metabolism-related gene polymorphisms and risk of breast cancer. 29(2), 356-362.

Volga Syamala, Vani Syamala, V Sheeja, Ratheesan Kuttan, Rajan Balakrishnan, Ravindran Ankathil (2010) Possible Risk Modification by Polymorphisms of Estrogen Metabolizing Genes in Familial Breast Cancer Susceptibility in an Indian Population. 28(3), 304-311.

Ping Wang, Sanqiang Li, Meilin Wang, Jing He, Shoumin Xi (2017) Association of MTRR A66G polymorphism with cancer susceptibility: Evidence from 85 studies. 8(2), 266-277.

A Weiner, U Boyarskikh, E Voronina, I Selezneva, T Sinkina, A Lazarev (2012) Polymorphisms in the folate-metabolizing genes MTR, MTRR, and CBS and breast cancer risk. 36(2), 95-e100.

Chunjie Wen, Lanxiang Wu, Lijuan Fu, Bing Wang, Honghao Zhou (2017) Unifying mechanism in the initiation of breast cancer by metabolism of estrogen. 16(2), 1001-1006.

Aaron Wilson, Robert Platt, Qing Wu, Daniel Leclerc, Benedicte Christensen, Hong Yang, Roy Gravel, Rima Rozen (1999) A Common Variant in Methionine Synthase Reductase Combined with Low Cobalamin (Vitamin B12) Increases Risk for Spina Bifida. 67(4), 317-323.

Lina Zhang, Lin Gu, Biyun Qian, Xishan Hao, Wei Zhang, Qingyi Wei, Kexin Chen (2009) Association of genetic polymorphisms of ER-α and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women. 114(2), 327-338.